Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 10/10

vs
industry
vs
history
Cash to Debt No Debt
SSH's Cash to Debt is ranked higher than
98% of the 389 Companies
in the Global Medical Devices industry.

( Industry Median: 3.52 vs. SSH: No Debt )
SSH' s 10-Year Cash to Debt Range
Min: No Debt   Max: No Debt
Current: No Debt

Equity to Asset 0.95
SSH's Equity to Asset is ranked higher than
99% of the 374 Companies
in the Global Medical Devices industry.

( Industry Median: 0.62 vs. SSH: 0.95 )
SSH' s 10-Year Equity to Asset Range
Min: 0.95   Max: 0.95
Current: 0.95

Interest Coverage No Debt
SSH's Interest Coverage is ranked higher than
86% of the 207 Companies
in the Global Medical Devices industry.

( Industry Median: 117.58 vs. SSH: No Debt )
SSH' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

F-Score: 5
Z-Score: 12.80
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -38764.41
SSH's Operating margin (%) is ranked lower than
59% of the 376 Companies
in the Global Medical Devices industry.

( Industry Median: 6.09 vs. SSH: -38764.41 )
SSH' s 10-Year Operating margin (%) Range
Min: -38764.41   Max: -358.24
Current: -38764.41

-38764.41
-358.24
Net-margin (%) -36877.97
SSH's Net-margin (%) is ranked lower than
59% of the 376 Companies
in the Global Medical Devices industry.

( Industry Median: 4.58 vs. SSH: -36877.97 )
SSH' s 10-Year Net-margin (%) Range
Min: -36877.97   Max: -358.24
Current: -36877.97

-36877.97
-358.24
ROE (%) -42.06
SSH's ROE (%) is ranked lower than
51% of the 370 Companies
in the Global Medical Devices industry.

( Industry Median: 5.10 vs. SSH: -42.06 )
SSH' s 10-Year ROE (%) Range
Min: -728.78   Max: -42.06
Current: -42.06

-728.78
-42.06
ROA (%) -39.40
SSH's ROA (%) is ranked lower than
52% of the 386 Companies
in the Global Medical Devices industry.

( Industry Median: 3.09 vs. SSH: -39.40 )
SSH' s 10-Year ROA (%) Range
Min: -328.79   Max: -39.4
Current: -39.4

-328.79
-39.4
ROC (Joel Greenblatt) (%) -3896.25
SSH's ROC (Joel Greenblatt) (%) is ranked lower than
57% of the 385 Companies
in the Global Medical Devices industry.

( Industry Median: 12.53 vs. SSH: -3896.25 )
SSH' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -9153.73   Max: -482.55
Current: -3896.25

-9153.73
-482.55
EBITDA Growth (%) 462.50
SSH's EBITDA Growth (%) is ranked higher than
100% of the 280 Companies
in the Global Medical Devices industry.

( Industry Median: -2.90 vs. SSH: 462.50 )
SSH' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 492.5
Current: 462.5

0
492.5
EPS Growth (%) 340.50
SSH's EPS Growth (%) is ranked higher than
100% of the 268 Companies
in the Global Medical Devices industry.

( Industry Median: -2.00 vs. SSH: 340.50 )
SSH' s 10-Year EPS Growth (%) Range
Min: 0   Max: 482.8
Current: 340.5

0
482.8
» SSH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

SSH Guru Trades in

SSH Guru Trades in

Q3 2013

SSH Guru Trades in Q3 2013

Jim Simons 17,000 sh (New)
» More
Q4 2013

SSH Guru Trades in Q4 2013

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with SSH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 2.00
SSH's P/B is ranked higher than
79% of the 414 Companies
in the Global Medical Devices industry.

( Industry Median: 3.39 vs. SSH: 2.00 )
SSH' s 10-Year P/B Range
Min: 0   Max: 11.6
Current: 2

0
11.6
P/S 709.10
SSH's P/S is ranked lower than
87% of the 414 Companies
in the Global Medical Devices industry.

( Industry Median: 3.15 vs. SSH: 709.10 )
SSH' s 10-Year P/S Range
Min: 0   Max: 2113.9
Current: 709.1

0
2113.9
Current Ratio 18.11
SSH's Current Ratio is ranked higher than
99% of the 246 Companies
in the Global Medical Devices industry.

( Industry Median: 2.86 vs. SSH: 18.11 )
SSH' s 10-Year Current Ratio Range
Min: 1.06   Max: 63.13
Current: 18.11

1.06
63.13
Quick Ratio 18.11
SSH's Quick Ratio is ranked higher than
99% of the 246 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. SSH: 18.11 )
SSH' s 10-Year Quick Ratio Range
Min: 1.06   Max: 63.13
Current: 18.11

1.06
63.13

Valuation & Return

vs
industry
vs
history
Price/Net Cash 2.10
SSH's Price/Net Cash is ranked higher than
99% of the 414 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. SSH: 2.10 )
SSH' s 10-Year Price/Net Cash Range
Min: 2.2   Max: 31.61
Current: 2.1

2.2
31.61
Price/Net Current Asset Value 2.10
SSH's Price/Net Current Asset Value is ranked higher than
99% of the 414 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. SSH: 2.10 )
SSH' s 10-Year Price/Net Current Asset Value Range
Min: 2.2   Max: 31.61
Current: 2.1

2.2
31.61
Price/Tangible Book 2.00
SSH's Price/Tangible Book is ranked higher than
87% of the 414 Companies
in the Global Medical Devices industry.

( Industry Median: 5.80 vs. SSH: 2.00 )
SSH' s 10-Year Price/Tangible Book Range
Min: 2.13   Max: 32.6
Current: 2

2.13
32.6
Forward Rate of Return (Yacktman) 362.91
SSH's Forward Rate of Return (Yacktman) is ranked higher than
100% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 1.36 vs. SSH: 362.91 )
SSH' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 0   Max: 0
Current: 362.91

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:SHC.Australia, 22S.Germany
Sunshine Heart, Inc. was incorporated in Delaware on August 22, 2002. The company is an early-stage medical device company engaged in developing, manufacturing and commercializing its C-Pulse Heart Assist System for treatment of Class III and ambulatory Class IV heart failure. Its C-Pulse Heart Assist System utilizes the scientific principles of intra-aortic balloon counter-pulsation applied in an extra-aortic approach to assist the left ventricle by reducing the workload required to pump blood throughout the body, while increasing blood flow to the coronary arteries. It is in the process of obtaining regulatory approvals necessary to sell its product. Combined, these potential benefits may help reverse the heart failure process or maintain the patient's current condition, thereby potentially preventing the need for later-stage heart failure devices, such as LVADs, artificial hearts or transplants. Its competitors include: AbioMed, Inc., Berlin Heart GmbH, CardioKinetix, Inc., CircuLite, Inc. & HeartWare International Inc. Its business is subject to extensive federal and state government regulation.
» More Articles for SSH

Headlines

Articles On GuruFocus.com
No related article found.


More From Other Websites
SUNSHINE HEART, INC. Financials Aug 19 2014
Sunshine Heart's C-Pulse(R) System Allows Father to Attend Daughter's Wedding Aug 19 2014
Sunshine Heart's C-Pulse(R) System Allows Father to Attend Daughter's Wedding Aug 19 2014
Sunshine Heart (SSH) in Focus: Stock Moves 7.9% Higher Aug 14 2014
SUNSHINE HEART, INC. Files SEC form 10-Q, Quarterly Report Aug 12 2014
Sunshine Heart Announces Second Quarter and Six Months 2014 Financial Results and Corporate Update Aug 12 2014
Sunshine Heart Announces Second Quarter and Six Months 2014 Financial Results and Corporate Update Aug 12 2014
Sunshine Heart to Present at the 34th Annual Canaccord Genuity Growth Conference Aug 05 2014
Sunshine Heart to Present at the 34th Annual Canaccord Genuity Growth Conference Aug 05 2014
Sunshine Heart to Release Second Quarter 2014 Results on August 12, 2014 Jul 31 2014
Sunshine Heart to Release Second Quarter 2014 Results on August 12, 2014 Jul 31 2014
Sunshine Heart Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Jul 11 2014
Sunshine Heart Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Jul 11 2014
Micro Cap Sunshine Heart Faces Medical Device Industry Challenges, Hires Boston Scientific And... Jun 30 2014
Sunshine Heart Appoints Brian Brown as Senior Vice President of Operations and Technology Jun 16 2014
Sunshine Heart to Present at 2014 Wells Fargo Healthcare Conference Jun 10 2014
SUNSHINE HEART, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 04 2014
Sunshine Heart Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) Jun 02 2014
Will Sunshine Heart Get Schooled If Enrollment Disappoints Again? May 13 2014
SUNSHINE HEART, INC. Files SEC form 10-Q, Quarterly Report May 13 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide